JAC Advance Access originally published online on April 10, 2006
Journal of Antimicrobial Chemotherapy 2006 57(6):1055-1064; doi:10.1093/jac/dkl113
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reviews |
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)
1 University of Brescia Brescia, Italy 2 Tor Vergata University Rome, Italy 3 University of Foggia Foggia, Italy 4 INMI Rome, Italy 5 University of Turin Turin, Italy 6 University of Bologna Bologna, Italy 7 Università Vita-Salute S. Raffaele, Milan, Italy 8 Catholic University Rome, Italy 9 Ospedale S. Paolo Milan, Italy 10 Campus Biomedico Rome, Italy 11 University of Pavia IRCCS Policlinico S. Matteo, Pavia, Italy 12 Ospedale L. Sacco Milan, Italy 13 Ospedali Riuniti Bergamo, Italy 14 Ospedale S. Maria Annunziata Florence, Italy
*Correspondence address. Clinica di Malattie Infettive e Tropicali, Università degli Studi di Brescia, P. le Spedali Civili 1, I-25123 Brescia, Italy. Tel:+39-030-3996624; Fax: +39-030-303061; E-mail: torti.carlo{at}libero.it
A panel of leading Italian specialists in infectious diseases, virologists and immunologists met in Rome in 2005 to review critical data and discuss recommendations for each of the key questions in antiretroviral therapy today: When to start treatment? How to start? When to switch? What to switch to? Whether to stop or not to stop treatment, and how? The method of a nominal group meeting was used and recommendations were graded for their strength and quality using a system based on the one adopted by the Infectious Diseases Society of America. Main conclusions are summarized and critically discussed in this consensus statement, as well as some of the most recent data supporting these recommendations are provided.
Keywords: HIV , HAART , guidelines